SAN FRANCISCO--(BUSINESS WIRE)--Rune Labs, a leader in precision medicine for Parkinson's disease, celebrates the signing of the National Plan to End Parkinson's Disease into law. This landmark legislation aims to unite federal and philanthropic efforts to diagnose and treat Parkinson's Disease, helping to ensure access to necessary care for American families. Brian Pepin, CEO of Rune Labs, expressed his enthusiasm: "The signing of the National Plan to End Parkinson's Disease into law is an imp
Rune Labs is a California-based data analytics company that offers solutions such as medication tracking and clinical trial support for clinicians and patients.